Can psilocybin help relieve the mental health burden of clinicians affected by the COVID-19 pandemic? That’s a question University of Washington researchers aim to address in a new clinical trial testing the psychedelic drug in combination with psychotherapy.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
